Letters Minneapolis (Lopez, Folsom); Ciccarone Center for the Prevention of Heart Medication use was verified by reviewing medications Disease, Johns Hopkins School of Medicine, Baltimore, Maryland (Blaha); that participants brought to the visit. We analyzed the preva- Center for Innovations, Michael E. DeBakey Veterans Affairs Medical Center, lence of indications for statin therapy according to ACC/AHA Houston, Texas (Virani); Department of Epidemiology, Johns Hopkins guidelines and ATP III guidelines (which were the most rel- Bloomberg School of Public Health, Baltimore, Maryland (Coresh); Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, evant guidelines at the time of ARIC visit 5) and the use of Houston, Texas (Ballantyne); Houston Methodist DeBakey Heart and Vascular statins and other medications to lower lipid levels. Center, Houston, Texas (Ballantyne). Corresponding Author: Michael D. Miedema, MD, MPH, Minneapolis Heart Results | A considerable portion of the ARIC cohort used Institute, Minneapolis Heart Institute Foundation, 800 E 28th St, Minneapolis, medication to lower lipid levels at visit 5, but uncontrolled MN 55414 (firstname.lastname@example.org). hyperlipidemia was still common according to the ATP III Published Online: November 17, 2014. doi:10.1001/jamainternmed.2014.6288. guidelines then in place (Table 1). Individuals with a high Author Contributions: Dr Miedema and
JAMA Internal Medicine – American Medical Association
Published: Jan 1, 2015
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera